Elanco Animal Health (ELAN) EBIT: 2016-2024
Historic EBIT for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to -$1.5 billion.
- Elanco Animal Health's EBIT rose 149.25% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 105.29%. This contributed to the annual value of -$1.5 billion for FY2024, which is 51.54% up from last year.
- Per Elanco Animal Health's latest filing, its EBIT stood at -$1.5 billion for FY2024, which was up 51.54% from -$3.1 billion recorded in FY2023.
- Over the past 5 years, Elanco Animal Health's EBIT peaked at -$1.5 billion during FY2024, and registered a low of -$3.1 billion during FY2023.
- Its 3-year average for EBIT is -$2.2 billion, with a median of -$2.0 billion in 2022.
- Per our database at Business Quant, Elanco Animal Health's EBIT plummeted by 68.39% in 2020 and then soared by 51.54% in 2024.
- Elanco Animal Health's EBIT (Yearly) stood at -$2.3 billion in 2020, then dropped by 15.32% to -$2.7 billion in 2021, then rose by 26.56% to -$2.0 billion in 2022, then crashed by 57.48% to -$3.1 billion in 2023, then soared by 51.54% to -$1.5 billion in 2024.